| TCGA-LIHC cohort | ICGC-LIRP-JI cohort |
---|---|---|
No. of patients | 209 | 231 |
Age (median, range) | 59 (16–90) | 67 (31–89) |
Gender | ||
Female | 65 (31.1%) | 61 (26.4%) |
Male | 144 (68.9%) | 170 (73.6%) |
Grade | ||
Grade 1 | 35 (16.7%) | NA |
Grade 2 | 103 (49.3%) | NA |
Grade 3 | 62 (29.7%) | NA |
Grade 4 | 7(3.3%) | NA |
Unknown | 2 (1.0%) | NA |
Stage | ||
I | 91 (43.5%) | 36 (15.6%) |
II | 54 (25.8%) | 105 (45.5%) |
III | 49 (23.4%) | 71 (30.7%) |
IV | 1 (0.5%) | 19 (8.2%) |
Unknown | 14 (6.7%) | 0 (0%) |
Survival status | ||
Alive | 159 (76.1%) | 189 (81.8%) |
Deceased | 50 (23.9%) | 42 (18.2%) |
Follow up (median, range) | 588 (1–1363) | 900 (10–2160) |